Posted on:
Two leading cardiovascular experts have been appointed to a prestigious world expert panel to reduce rates of cardiovascular disease in women. Royal North Shore Hospital (RNSH) interventional cardiologist and Kolling Institute researcher, Professor Gemma Figtree, and RNSH senior hospital scientist and Kolling Institute researcher, Dr Anastasia Mihailidou, have been appointed commissioners of The Lancet women
Category:
Posted on:
A team of researchers from the Kolling Institute, The University of Sydney, Monash University and La Trobe University have led a global call to action to accelerate new approaches for cardiovascular disease (CVD) drug solutions. CVD is the leading cause of death globally. Since the start of the pandemic approximately 18 million people have died
Category:
Posted on:
Two of our leading researchers will drive key Australian projects following a funding announcement from the National Health and Medical Research Council. (NHMRC) More than $1.4 million from the partnership grant program will go to Kolling researcher and RNSH interventional cardiologist Professor Gemma Figtree and her team for a study to reduce coronary artery disease.
Category:
Posted on:
Kolling researcher and Royal North Shore Hospital cardiologist Dr Rebecca Kozor will lead a world-first study using MRI technology to improve the diagnosis of heart failure. The trial has been made possible following a $50,000 Cardiac Society of Australia and New Zealand-Boehringer Ingelheim innovation grant. Dr Kozor has welcomed the funding to quantify pulmonary congestion
Category:
Posted on:
Professor Gemma Figtree has led a successful bid for a Cardiovascular Centre of Excellence, securing $2.5 million in funding from the National Health and Medical Research Council. (NHMRC) Around 20 national and international collaborators will be involved in the research, targeting the global heart disease epidemic through new diagnostic techniques and prevention strategies. Professor Figtree
Category:
Posted on:
Generous funding from the Raymond E Purves Foundation will support innovative research to identify how osteoarthritis causes cardiovascular disease. $100,000 will go towards Dr Cindy Shu to continue her valuable project to better define the link between osteoarthritis and heart disease, and inform improved treatment. Nearly 2.5 million Australians currently suffer from osteoarthritis, with the
Category:
Posted on:
Two Kolling Institute researchers have welcomed a significant funding boost through a large NSW Government program to help tackle Australia’s number one killer, heart disease. Professors Gemma Figtree and Martin Ugander have each been awarded a $750,000 grant to encourage researchers to find breakthroughs and help establish NSW as a centre for research excellence. The
Category:
Copyright © 2026 Kolling Institute
All rights reserved